Adaptive Biotechnologies Corp
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $277.0 | $179.0 | $170.3 | $185.3 | $154.3 |
| Operating income | -$57.1 | -$162.5 | -$227.0 | -$200.2 | -$209.0 |
| Net income | -$59.5 | -$159.5 | -$225.2 | -$200.2 | -$207.3 |
| Cash Flow Statement | |||||
| Free cash flow | -$48.9 | -$98.9 | -$167.0 | -$200.3 | -$254.5 |
Shares outstanding 159.6M · Free float 94.1%
Annual filing data through FY ended December 31, 2025; float as of September 29, 2026.